NCT07595809

Brief Summary

Heart failure with reduced ejection fraction (HFrEF) is frequently associated with abnormalities in body composition, including reduced skeletal muscle mass and sarcopenia, which are independent predictors of reduced exercise tolerance, impaired quality of life, and increased mortality. Despite advances in pharmacological therapy, evidence-based non-pharmacological strategies aimed at preventing muscle mass loss remain limited. This randomized controlled trial aims to evaluate the effects of dietary intervention based on the DASH diet with high-protein elements, resistance exercise training, and their combination on skeletal muscle mass, functional capacity, echocardiographic parameters, biochemical markers, and quality of life in patients with HFrEF.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
10mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
May 2023Apr 2027

Study Start

First participant enrolled

May 8, 2023

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

May 13, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 19, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

3.2 years

First QC Date

May 13, 2026

Last Update Submit

May 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in skeletal muscle mass

    Quantitative assessment of skeletal muscle mass change over the study period.

    Baseline to 6 months

Secondary Outcomes (4)

  • Change in quality of life

    Baseline to 6 months

  • Change in exercise capacity

    Baseline to 6 months

  • Change in echocardiographic parameters of diastolic function

    Baseline to 6 months

  • Change in laboratory biomarkers

    Baseline to 6 months

Study Arms (4)

Standard medical care

NO INTERVENTION

Resistance Exercise Training

EXPERIMENTAL

Elastic resistance bands and structured exercise education provided by a medical rehabilitation specialist.

Behavioral: Resistance Exercise

Dietary Intervention

EXPERIMENTAL

Individualized 14-day meal plan based on the DASH diet with high-protein components.

Behavioral: Dietary Intervention

Combined Dietary and Exercise Intervention

EXPERIMENTAL

Combination of dietary counseling and resistance exercise training as described above.

Behavioral: Resistance ExerciseBehavioral: Dietary Intervention

Interventions

The exercise intervention includes resistance training using elastic bands, with instruction and follow-up provided by a medical rehabilitation specialist.

Combined Dietary and Exercise InterventionResistance Exercise Training

Individualized 14-day meal plan based on the DASH diet with high-protein components.

Combined Dietary and Exercise InterventionDietary Intervention

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent obtained prior to participation Age \>30 years Diagnosis of chronic heart failure, NYHA functional class I-III Left ventricular ejection fraction \<40%

You may not qualify if:

  • NYHA functional class IV heart failure Potentially reversible cause of heart failure Estimated glomerular filtration rate \<30 mL/min Severe anemia (hemoglobin \<9 g/dL) Uncontrolled thyroid disease Severe hepatic dysfunction History of hyperkalemia or hyperkalemia at baseline Epilepsy Presence of joint endoprostheses Gastrointestinal disorders limiting adherence to the DASH diet Physical limitations precluding participation in structured exercis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

2nd Department and Clinical Ward of Cardiology Specialist Hospital in Zabrze, Poland

Zabrze, Silesian Voivodeship, 41-800, Poland

RECRUITING

MeSH Terms

Interventions

Resistance TrainingDiet Therapy

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNutrition Therapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 13, 2026

First Posted

May 19, 2026

Study Start

May 8, 2023

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

April 1, 2027

Last Updated

May 19, 2026

Record last verified: 2026-05

Locations